Endocrinology


	Article Title	Year	Authour(s)	Journal	Subject	Expert Rating	Evidence Ranking
1.	Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia	2006	Schrier, R.W.	N Engl J Med	Endocrinology		A
2.	Hyponatremia Among Runners in the Boston Marathon	2005	Almond, C.S.D., Shin, A.Y., Fortescue, E.B.	N Engl J Med	Endocrinology		B